20 Recruiting Triple Negative Breast Cancer Phase 2 Clinical Trials
Active phase 2 studies for triple negative breast cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Triple Negative Breast Cancer studiesPhase 2 Studies for Triple Negative Breast Cancer
Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
📍 University of Illinois — Chicago, Illinois
View Study & Checklist ➔Ribociclib and Bicalutamide in AR+ TNBC
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
📍 The University of Kansas Cancer Center - Clinical Research Center — Fairway, Kansas
View Study & Checklist ➔Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer
📍 The Queen Elizabeth Hospital — Bridgetown, Saint Michael
View Study & Checklist ➔Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients
📍 Medical University of South Carolina — Charleston, South Carolina
View Study & Checklist ➔PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
📍 Wake Forest Baptist Health Sciences — Winston-Salem, North Carolina
View Study & Checklist ➔A Study of Tetrathiomolybdate (TM) Plus Capecitabine
📍 Indiana University Simon Cancer Center — Indianapolis, Indiana
View Study & Checklist ➔ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
📍 Emory University Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
📍 Mayo Clinic Comprehensive Cancer Center — Phoenix, Arizona
View Study & Checklist ➔Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
📍 Natera, Inc. (Data and Specimen Analysis Only) — San Carlos, California
View Study & Checklist ➔Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
📍 Morton Plant Hospital - Baycare Health System — Clearwater, Florida
View Study & Checklist ➔Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
📍 Stanford University — Stanford, California
View Study & Checklist ➔Study of Screening Brain MRIs in Stage IV Breast Cancer
📍 Morton Plant Mease- Baycare — Clearwater, Florida
View Study & Checklist ➔A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
📍 Los Angeles Cancer Network (LACN) - Good Sam — Los Angeles, California
View Study & Checklist ➔Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
📍 Ellison Institute of Technology (EITM) — Los Angeles, California
View Study & Checklist ➔A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔